33
/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Create
Close
Create a timeline
Public timelines
Library
FAQ
Download
Export
Duplicate
Premium
Embed
Share
Ocular Therapeutix
Category:
Other
Updated:
5 Feb 2020
0
0
256
Contributors
Created by
Nathan
Attachments
Comments
Events
Founded
Series A $1.17M (Undisclosed Investors)
Series B $6.09 M Pinnacle Ventures SV Health Investors Versant Venture Management
Series C $21.53 M Polaris Partners SV Health Investors Versant Venture Management
Series D $23.79 M Ascension Ventures Baxter Ventures Polaris Partners Sparta Capital Partners SV Health Investors Versant Venture Management
Debt $20 M Flexpoint Ford Silicon Valley Bank
IPO $65 M
Stock Drops 30%
Dextenza Approved
Periods
Phase 2 Dextenza Post-Surgical Inflammation and Pain
Phase 3 Dextenza Post-Surgical Inflammation and Pain
About & Feedback
Terms
Privacy
Library
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments